Ramses thank you for sharing and my simplified assessment of the company and view of events as folows:
1 Excellent management and products - 9/10
2 ASX300 inclusion - 6.5/10
3 NASDAQ listing after annual report to ASX/NASDAQ due end of month and therefore expect ann by end of oct - 8/10
4 Positive interim Phase2B update ann before end of year -7/10
5 Dubai sales starts by end of year - 7/10
6 If treatment is successful and sales in Australia/Europe - 9.5/10
7 Completion of Phase3 recruitment - 6.5/10
8 Final FDA approval/worldwide sales - 10/10
Above all IMHO and GL to all SH
Ramses thank you for sharing and my simplified assessment of the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 24.0¢ | $129.2K | 531.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 150003 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 40000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |